AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 7956585 — intervention group
Group type: EXPERIMENTAL
Intervention: Closed technique (surgical excision and primary closure, Group A)
Number of subjects: 110
Study 7956585 — intervention group
Group type: COMPARATOR
Intervention: Open technique (Obeid's surgical excision, Group B)
Number of subjects: 110
Study 3312614 — intervention group
Group type: EXPERIMENTAL
Intervention: Relaxation Training (RT)
Number of subjects: 0
Study 31655119 — intervention group
Group type: EXPERIMENTAL
Intervention: UCBT
Number of subjects: 45
Study 31655119 — intervention group
Group type: COMPARATOR
Intervention: haplo‐SCT
Number of subjects: 45
Study 30142868 — intervention group
Group type: EXPERIMENTAL
Intervention: PEG‐IFN‐α‐2b and ADV
Number of subjects: 102
Study 30142868 — intervention group
Group type: COMPARATOR
Intervention: PEG‐IFN‐α‐2b alone
Number of subjects: 102
Study 27723839 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischemic preconditioning (RIPC)
Number of subjects: 102
Study 27723839 — intervention group
Group type: COMPARATOR
Intervention: Sham ischemic preconditioning (Control)
Number of subjects: 102
Study 24516190 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT‐288 10mg
Number of subjects: 214
Study 24516190 — intervention group
Group type: EXPERIMENTAL
Intervention: ABT‐288 25mg
Number of subjects: 214
Study 24516190 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 214
Study 21940765 — intervention group
Group type: EXPERIMENTAL
Intervention: One-page patient-specific feedback form based on questionnaire responses to stimulate conversations about end-of-life care.
Number of subjects: 376
Study 21940765 — intervention group
Group type: COMPARATOR
Intervention: Control group (no feedback form), completed questionnaires but did not receive feedback.
Number of subjects: 376
Study 21940765 — intervention group
Group type: EXPERIMENTAL
Intervention: One-page patient-specific feedback form.
Number of subjects: 376
Study 21111100 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-carbohydrate lunch meal
Number of subjects: 14
Study 21111100 — intervention group
Group type: EXPERIMENTAL
Intervention: High-carbohydrate lunch meal
Number of subjects: 14
Study 17972110 — intervention group
Group type: EXPERIMENTAL
Intervention: d‐methylphenidate (d‐MPH)
Number of subjects: 57
Study 17972110 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 57
Study 15113946 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-fortified infant cereals with regular or low phytate content
Number of subjects: 0
Study 15113946 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron-fortified infant formula
Number of subjects: 0
Study 15113946 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron intake from 12 to 17 months
Number of subjects: 0
Study 15113946 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron intake from 6 to 11 months
Number of subjects: 0
Study 11688904 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha with amantadine
Number of subjects: 8
Study 11688904 — intervention group
Group type: COMPARATOR
Intervention: Interferon-alpha monotherapy
Number of subjects: 8
Study 11688904 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferon-alpha with or without amantadine
Number of subjects: 8
Study 9153520 — intervention group
Group type: EXPERIMENTAL
Intervention: Chronic alcoholics
Number of subjects: 40
Study 9153520 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 40
Study 7701056 — intervention group
Group type: EXPERIMENTAL
Intervention: Light therapy
Number of subjects: 15
Study 7701056 — intervention group
Group type: COMPARATOR
Intervention: Control group (age- and gender-matched)
Number of subjects: 15
Study 3300975 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg isosorbide 5‐mononitrate
Number of subjects: 15
Study 3300975 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg isosorbide 5‐mononitrate
Number of subjects: 15
Study 3300975 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg isosorbide 5‐mononitrate
Number of subjects: 15
Study 3300975 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 31488733 — intervention group
Group type: EXPERIMENTAL
Intervention: Noradrenergic and serotonergic antidepressants with 100 mg acetylsalicylic acid (ASA)
Number of subjects: 40
Study 31488733 — intervention group
Group type: EXPERIMENTAL
Intervention: Noradrenergic and serotonergic antidepressants without 100 mg acetylsalicylic acid (ASA)
Number of subjects: 40
Study 31488733 — intervention group
Group type: EXPERIMENTAL
Intervention: Noradrenergic and serotonergic antidepressants (both with and without ASA)
Number of subjects: 40
Study 31488733 — intervention group
Group type: COMPARATOR
Intervention: Healthy group (HG)
Number of subjects: 40
Study 29150395 — intervention group
Group type: EXPERIMENTAL
Intervention: Transradial access (TRA)
Number of subjects: 55
Study 29150395 — intervention group
Group type: COMPARATOR
Intervention: Transfemoral access (TFA)
Number of subjects: 55
Study 26493551 — intervention group
Group type: COMPARATOR
Intervention: Bipolar coagulation
Number of subjects: 109
Study 26493551 — intervention group
Group type: EXPERIMENTAL
Intervention: Suturing
Number of subjects: 109
Study 24568225 — intervention group
Group type: EXPERIMENTAL
Intervention: Pickle Juice (PJ)
Number of subjects: 9
Study 24568225 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypertonic Saline
Number of subjects: 9
Study 24568225 — intervention group
Group type: EXPERIMENTAL
Intervention: Deionized Water (DIW)
Number of subjects: 9
Study 24568225 — intervention group
Group type: COMPARATOR
Intervention: Pre-exercise
Number of subjects: 9
Study 23082941 — intervention group
Group type: EXPERIMENTAL
Intervention: Teacher-made models (TM)
Number of subjects: 144
Study 23082941 — intervention group
Group type: COMPARATOR
Intervention: Commercial model (CM)
Number of subjects: 144
Study 20338501 — intervention group
Group type: EXPERIMENTAL
Intervention: Bone marrow mononuclear cell therapy (BMC therapy)
Number of subjects: 0
Study 20338501 — intervention group
Group type: COMPARATOR
Intervention: BMCs contaminated with RBCs
Number of subjects: 0
Study 20338501 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated BMCs with added RBCs
Number of subjects: 0
Study 20338501 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher numbers of RBCs in BMC preparation
Number of subjects: 0
Study 17403067 — intervention group
Group type: EXPERIMENTAL
Intervention: First offender incarceration and treatment program
Number of subjects: 305
Study 17403067 — intervention group
Group type: COMPARATOR
Intervention: Control group (only incarcerated)
Number of subjects: 305
Study 17403067 — intervention group
Group type: EXPERIMENTAL
Intervention: First offender incarceration and treatment program (for ASPD participants)
Number of subjects: 305
Study 17403067 — intervention group
Group type: COMPARATOR
Intervention: Control group (for ASPD participants)
Number of subjects: 305
Study 17403067 — intervention group
Group type: EXPERIMENTAL
Intervention: First offender incarceration and treatment program (relative to control)
Number of subjects: 305
Study 15831714 — intervention group
Group type: EXPERIMENTAL
Intervention: Electrical acupoint stimulation at the Neiguan
Number of subjects: 14
Study 15831714 — intervention group
Group type: COMPARATOR
Intervention: Naloxone (80 microg/kg iv bolus injection)
Number of subjects: 14
Study 15831714 — intervention group
Group type: COMPARATOR
Intervention: Sham point stimulation
Number of subjects: 14
Study 11407429 — intervention group
Group type: EXPERIMENTAL
Intervention: Pseudohomophones with extant body rime relations
Number of subjects: 0
Study 9406270 — intervention group
Group type: EXPERIMENTAL
Intervention: Structured assessment of long-term mentally ill patients every six months
Number of subjects: 16
Study 9406270 — intervention group
Group type: COMPARATOR
Intervention: General practitioner consultations
Number of subjects: 16
Study 8220037 — intervention group
Group type: EXPERIMENTAL
Intervention: High-resolution sonographically guided catheterization
Number of subjects: 47
Study 8220037 — intervention group
Group type: COMPARATOR
Intervention: Conventional right internal jugular vein catheterization
Number of subjects: 47
Study 3323167 — intervention group
Group type: EXPERIMENTAL
Intervention: roxithromycin (150 mg bd)
Number of subjects: 76
Study 3323167 — intervention group
Group type: COMPARATOR
Intervention: doxycycline (200 mg once daily)
Number of subjects: 76
Study 30935544 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic neuro-cognitive imagery (DNI) training
Number of subjects: 20
Study 30935544 — intervention group
Group type: COMPARATOR
Intervention: In-home learning and exercise control
Number of subjects: 20
Study 29445655 — intervention group
Group type: EXPERIMENTAL
Intervention: Nonextensible lumbosacral orthosis (LSO) in addition to routine physical therapy
Number of subjects: 0
Study 29445655 — intervention group
Group type: COMPARATOR
Intervention: Routine physical therapy
Number of subjects: 0
Study 25458446 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound and electrical stimulator guided obturator nerve block using 5% phenol in aqueous solution
Number of subjects: 26
Study 25458446 — intervention group
Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 26
Study 23867158 — intervention group
Group type: EXPERIMENTAL
Intervention: Telephone- and Skype-based dietary counseling
Number of subjects: 48
Study 23867158 — intervention group
Group type: COMPARATOR
Intervention: Control condition providing print materials only
Number of subjects: 48
Study 20817628 — intervention group
Group type: EXPERIMENTAL
Intervention: Working in agriculture
Number of subjects: 188
Study 20817628 — intervention group
Group type: EXPERIMENTAL
Intervention: Working in livestock farming
Number of subjects: 188
Study 20817628 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to pesticides
Number of subjects: 188
Study 20817628 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to fertilizers
Number of subjects: 188
Study 20817628 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to disinfectants
Number of subjects: 188
Study 20817628 — intervention group
Group type: EXPERIMENTAL
Intervention: Exposure to salt based wood protection agents
Number of subjects: 188
Study 20817628 — intervention group
Group type: EXPERIMENTAL
Intervention: Working with plywood
Number of subjects: 188
Study 20817628 — intervention group
Group type: EXPERIMENTAL
Intervention: Working with coated wood
Number of subjects: 188
Study 20817628 — intervention group
Group type: EXPERIMENTAL
Intervention: Working in forestry
Number of subjects: 188
Study 18346173 — intervention group
Group type: EXPERIMENTAL
Intervention: Metformin 850 mg daily
Number of subjects: 60
Study 18346173 — intervention group
Group type: COMPARATOR
Intervention: Control group (dietary counselling only)
Number of subjects: 60
Study 16568505 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept 10 mg/kg
Number of subjects: 339
Study 16568505 — intervention group
Group type: EXPERIMENTAL
Intervention: Abatacept 2 mg/kg
Number of subjects: 339
Study 16568505 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 339
Study 12945222 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol 2.5 mg/HCTZ 6.25 mg
Number of subjects: 641
Study 12945222 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisoprolol 5 mg/HCTZ 6.25 mg
Number of subjects: 641
Study 12945222 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuation with Bisoprolol 2.5 mg/HCTZ 6.25 mg for 4 more weeks
Number of subjects: 641
Study 12945222 — intervention group
Group type: EXPERIMENTAL
Intervention: Up-titration to Bisoprolol 5 mg/HCTZ 6.25 mg
Number of subjects: 641
Study 10703152 — intervention group
Group type: EXPERIMENTAL
Intervention: Polyethylene glycol (PEG)
Number of subjects: 0
Study 9070520 — intervention group
Group type: EXPERIMENTAL
Intervention: Nailing after reaming
Number of subjects: 91
Study 9070520 — intervention group
Group type: COMPARATOR
Intervention: Nailing without reaming
Number of subjects: 91
Study 9070520 — intervention group
Group type: COMPARATOR
Intervention: Comparison of screws
Number of subjects: 91
Study 9070520 — intervention group
Group type: COMPARATOR
Intervention: Functional outcomes
Number of subjects: 91
Study 8373709 — intervention group
Group type: EXPERIMENTAL
Intervention: Clonidine (150 micrograms orally)
Number of subjects: 0
Study 8373709 — intervention group
Group type: COMPARATOR
Intervention: Change from upright to supine position
Number of subjects: 0
Study 8373709 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 8373709 — intervention group
Group type: EXPERIMENTAL
Intervention: Yohimbine (alpha 2‐adrenoceptor antagonist)
Number of subjects: 0
Study 8373709 — intervention group
Group type: EXPERIMENTAL
Intervention: Standing after yohimbine administration
Number of subjects: 0
Study 31102320 — intervention group
Group type: EXPERIMENTAL
Intervention: Blunt Blade (BB) subcision
Number of subjects: 28
Study 31102320 — intervention group
Group type: COMPARATOR
Intervention: Nokor needle subcision
Number of subjects: 28
Study 28766191 — intervention group
Group type: EXPERIMENTAL
Intervention: PAX Good Behavior Game (PAX GBG)
Number of subjects: 811
Study 28766191 — intervention group
Group type: COMPARATOR
Intervention: Treatment-as-usual
Number of subjects: 811
Study 26588822 — intervention group
Group type: EXPERIMENTAL
Intervention: Instruction with sham treatment (peppermint essence vapor)
Number of subjects: 56
Study 26588822 — intervention group
Group type: EXPERIMENTAL
Intervention: Conditioning with sham treatment (peppermint essence vapor)
Number of subjects: 56
Study 26588822 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of instruction and conditioning
Number of subjects: 56
Study 24509980 — intervention group
Group type: EXPERIMENTAL
Intervention: Allografts loaded with mesenchymal stem cells (MSCs)
Number of subjects: 60
Study 24509980 — intervention group
Group type: COMPARATOR
Intervention: Allografts without mesenchymal stem cells (MSCs)
Number of subjects: 60
Study 21193234 — intervention group
Group type: EXPERIMENTAL
Intervention: MDCT‐XTe (BMI‐adapted scanning protocol with prospective ECG‐triggering)
Number of subjects: 119
Study 21193234 — intervention group
Group type: EXPERIMENTAL
Intervention: MDCT‐XT (standard prospective ECG‐triggering protocol)
Number of subjects: 119
Study 21193234 — intervention group
Group type: COMPARATOR
Intervention: MDCT‐Helical (retrospective ECG‐triggering)
Number of subjects: 119
Study 21193234 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective radiation dose for MDCT‐XTe
Number of subjects: 119
Study 21193234 — intervention group
Group type: EXPERIMENTAL
Intervention: Effective radiation dose for MDCT‐XT
Number of subjects: 119
Study 21193234 — intervention group
Group type: COMPARATOR
Intervention: Effective radiation dose for MDCT‐Helical
Number of subjects: 119
Study 20588189 — intervention group
Group type: EXPERIMENTAL
Intervention: AZD1305
Number of subjects: 50
Study 20588189 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 18718419 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents (SES)
Number of subjects: 400
Study 18718419 — intervention group
Group type: COMPARATOR
Intervention: Paclitaxel-eluting stents (PES)
Number of subjects: 400
Study 15943841 — intervention group
Group type: EXPERIMENTAL
Intervention: famotidine 20 mg b.d. (n = 48)
Number of subjects: 98
Study 15943841 — intervention group
Group type: COMPARATOR
Intervention: omeprazole once daily (n = 50)
Number of subjects: 98
Study 15943841 — intervention group
Group type: EXPERIMENTAL
Intervention: famotidine
Number of subjects: 98
Study 15943841 — intervention group
Group type: COMPARATOR
Intervention: omeprazole
Number of subjects: 98
Study 14663351 — intervention group
Group type: EXPERIMENTAL
Intervention: Transiently evoked otoacoustic emissions (TEOAEs) and tympanometry included in the protocol
Number of subjects: 72
Study 14663351 — intervention group
Group type: COMPARATOR
Intervention: Control group protocol (TEOAEs and tympanometry omitted)
Number of subjects: 72
Study 14663351 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group
Number of subjects: 72
Study 14663351 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 72
Study 9927114 — intervention group
Group type: EXPERIMENTAL
Intervention: Epoetin alfa
Number of subjects: 276
Study 9927114 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 276
Study 8736713 — intervention group
Group type: EXPERIMENTAL
Intervention: Heat-washout method
Number of subjects: 2
Study 8736713 — intervention group
Group type: COMPARATOR
Intervention: 133Xe-washout method
Number of subjects: 2
Study 1914097 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive 4-week in-hospital exercise program (training group with ejection fraction <30%)
Number of subjects: 39
Study 1914097 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive 4-week in-hospital exercise program (training group with ejection fraction 31-50%)
Number of subjects: 39
Study 1914097 — intervention group
Group type: COMPARATOR
Intervention: Minimal activity program (control group with ejection fraction <30%)
Number of subjects: 39
Study 1914097 — intervention group
Group type: COMPARATOR
Intervention: Minimal activity program (control group with ejection fraction 31-50%)
Number of subjects: 39
Study 6280836 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG immunotherapy (1 vial of high viability Pasteur BCG by scarification technique on days 8 and 15 of each 21-28 day treatment cycle)
Number of subjects: 298
Study 6280836 — intervention group
Group type: COMPARATOR
Intervention: No BCG immunotherapy
Number of subjects: 298
Study 6280836 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG immunotherapy (for patients who responded and survived longer than one year)
Number of subjects: 298
Study 6280836 — intervention group
Group type: COMPARATOR
Intervention: No BCG immunotherapy (for patients who responded and survived longer than one year)
Number of subjects: 298
Study 30573173 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (hip osteoarthritis)
Number of subjects: 125
Study 30573173 — intervention group
Group type: COMPARATOR
Intervention: Group 3 (healthy young women)
Number of subjects: 125
Study 30573173 — intervention group
Group type: COMPARATOR
Intervention: Group 2 (women without hip osteoarthritis)
Number of subjects: 125
Study 27834225 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-step approach with accompanying educational materials
Number of subjects: 230
Study 27834225 — intervention group
Group type: COMPARATOR
Intervention: Standard information available (control group)
Number of subjects: 230
Study 27834225 — intervention group
Group type: EXPERIMENTAL
Intervention: Six-step approach
Number of subjects: 230
Study 25421470 — intervention group
Group type: EXPERIMENTAL
Intervention: Micafungin 2 mg/kg/day
Number of subjects: 229
Study 25421470 — intervention group
Group type: EXPERIMENTAL
Intervention: Micafungin 1 mg/kg/day
Number of subjects: 229
Study 25421470 — intervention group
Group type: EXPERIMENTAL
Intervention: Micafungin 3 mg/kg/day
Number of subjects: 229
Study 24661464 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesia portable kinematic system
Number of subjects: 18
Study 24661464 — intervention group
Group type: COMPARATOR
Intervention: Clinician ratings
Number of subjects: 18
Study 21851025 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion therapy controlled by transesophageal dopplerography (Cardio Q apparatus)
Number of subjects: 72
Study 21851025 — intervention group
Group type: COMPARATOR
Intervention: Infusion therapy assessed clinically (BP, CVP, HR, diuresis)
Number of subjects: 72
Study 21851025 — intervention group
Group type: EXPERIMENTAL
Intervention: Infusion therapy controlled by transesophageal dopplerography
Number of subjects: 72
Study 21851025 — intervention group
Group type: COMPARATOR
Intervention: Infusion therapy assessed clinically
Number of subjects: 72
Study 19321851 — intervention group
Group type: EXPERIMENTAL
Intervention: Fine arts visits (films, concerts, art exhibitions, singing in a choir) once a week for 8 weeks
Number of subjects: 101
Study 19321851 — intervention group
Group type: COMPARATOR
Intervention: Control group (no fine arts visits during the trial)
Number of subjects: 101
Study 17392668 — intervention group
Group type: EXPERIMENTAL
Intervention: High thoracic epidural analgesia (HTEA)
Number of subjects: 61
Study 17392668 — intervention group
Group type: COMPARATOR
Intervention: Intravenous morphine analgesia (control)
Number of subjects: 61
Study 17392668 — intervention group
Group type: COMPARATOR
Intervention: Control group (intravenous morphine)
Number of subjects: 61
Study 15147921 — intervention group
Group type: EXPERIMENTAL
Intervention: Environmental control education, allergen-proof encasements, pest extermination, and a HEPA air cleaner at the beginning of the study.
Number of subjects: 100
Study 15147921 — intervention group
Group type: COMPARATOR
Intervention: Control group received the same intervention at the end of the study.
Number of subjects: 100
Study 15147921 — intervention group
Group type: EXPERIMENTAL
Intervention: Home environments, NO(2), O(3), airborne particulates, and allergens evaluated at baseline and at 6 and 12 months.
Number of subjects: 100
Study 11216083 — intervention group
Group type: EXPERIMENTAL
Intervention: Flecainide
Number of subjects: 352
Study 11216083 — intervention group
Group type: EXPERIMENTAL
Intervention: Propafenone
Number of subjects: 352
Study 11216083 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 352
Study 11216083 — intervention group
Group type: EXPERIMENTAL
Intervention: Flecainide and Propafenone
Number of subjects: 352
Study 9932219 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin Lispro (5 min before the meal)
Number of subjects: 7
Study 9932219 — intervention group
Group type: COMPARATOR
Intervention: Regular insulin (20 min before the meal)
Number of subjects: 7
Study 8092452 — intervention group
Group type: EXPERIMENTAL
Intervention: midazolam, 0.2 mg/kg BW orally
Number of subjects: 38
Study 8092452 — intervention group
Group type: EXPERIMENTAL
Intervention: nordazepam, 0.2 mg/kg BW orally
Number of subjects: 38
Study 8092452 — intervention group
Group type: EXPERIMENTAL
Intervention: atropine, 0.5 mg, plus promethazine, 50 mg i.m.
Number of subjects: 38
Study 8092452 — intervention group
Group type: EXPERIMENTAL
Intervention: atropine, 0.5 mg, plus promethazine, 50 mg, plus pethidine, 0.7 mg/kg BW i.m.
Number of subjects: 38
Study 2967711 — intervention group
Group type: EXPERIMENTAL
Intervention: sufentanil 5 micrograms kg‐1
Number of subjects: 40
Study 2967711 — intervention group
Group type: COMPARATOR
Intervention: fentanyl 25 micrograms kg‐1
Number of subjects: 40
Study 29438414 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher baseline plasma PFAS concentrations (PFOS, PFOA, PFNA, PFHxS, PFDA)
Number of subjects: 621
Study 29438414 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher baseline plasma PFAS concentrations
Number of subjects: 621